240 related articles for article (PubMed ID: 34174248)
1. Cinnamic acid inhibits Zika virus by inhibiting RdRp activity.
Chen Y; Li Z; Pan P; Lao Z; Xu J; Li Z; Zhan S; Liu X; Wu Y; Wang W; Li G
Antiviral Res; 2021 Aug; 192():105117. PubMed ID: 34174248
[TBL] [Abstract][Full Text] [Related]
2. Non-nucleoside Inhibitors of Zika Virus RNA-Dependent RNA Polymerase.
Gharbi-Ayachi A; Santhanakrishnan S; Wong YH; Chan KWK; Tan ST; Bates RW; Vasudevan SG; El Sahili A; Lescar J
J Virol; 2020 Oct; 94(21):. PubMed ID: 32796069
[TBL] [Abstract][Full Text] [Related]
3. Identification of Inhibitors of ZIKV Replication.
Morales Vasquez D; Park JG; Ávila-Pérez G; Nogales A; de la Torre JC; Almazan F; Martinez-Sobrido L
Viruses; 2020 Sep; 12(9):. PubMed ID: 32961956
[TBL] [Abstract][Full Text] [Related]
4. Harringtonine Inhibits Zika Virus Infection through Multiple Mechanisms.
Lai ZZ; Ho YJ; Lu JW
Molecules; 2020 Sep; 25(18):. PubMed ID: 32906689
[TBL] [Abstract][Full Text] [Related]
5. Ribavirin inhibits Zika virus (ZIKV) replication in vitro and suppresses viremia in ZIKV-infected STAT1-deficient mice.
Kamiyama N; Soma R; Hidano S; Watanabe K; Umekita H; Fukuda C; Noguchi K; Gendo Y; Ozaki T; Sonoda A; Sachi N; Runtuwene LR; Miura Y; Matsubara E; Tajima S; Takasaki T; Eshita Y; Kobayashi T
Antiviral Res; 2017 Oct; 146():1-11. PubMed ID: 28818572
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol affects Zika virus replication in vitro.
Mohd A; Zainal N; Tan KK; AbuBakar S
Sci Rep; 2019 Oct; 9(1):14336. PubMed ID: 31586088
[TBL] [Abstract][Full Text] [Related]
7. Favipiravir and Ribavirin Inhibit Replication of Asian and African Strains of Zika Virus in Different Cell Models.
Kim JA; Seong RK; Kumar M; Shin OS
Viruses; 2018 Feb; 10(2):. PubMed ID: 29425176
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic fidaxomicin is an RdRp inhibitor as a potential new therapeutic agent against Zika virus.
Yuan J; Yu J; Huang Y; He Z; Luo J; Wu Y; Zheng Y; Wu J; Zhu X; Wang H; Li M
BMC Med; 2020 Jul; 18(1):204. PubMed ID: 32731873
[TBL] [Abstract][Full Text] [Related]
9. Suppression of Zika Virus Infection in the Brain by the Antiretroviral Drug Rilpivirine.
Sariyer IK; Gordon J; Burdo TH; Wollebo HS; Gianti E; Donadoni M; Bellizzi A; Cicalese S; Loomis R; Robinson JA; Carnevale V; Steiner J; Ozdener MH; Miller AD; Amini S; Klein ML; Khalili K
Mol Ther; 2019 Dec; 27(12):2067-2079. PubMed ID: 31653397
[TBL] [Abstract][Full Text] [Related]
10. Antiviral activity of N-(4-hydroxyphenyl) retinamide (4-HPR) against Zika virus.
Pitts JD; Li PC; de Wispelaere M; Yang PL
Antiviral Res; 2017 Nov; 147():124-130. PubMed ID: 29051080
[TBL] [Abstract][Full Text] [Related]
11. The Compound SBI-0090799 Inhibits Zika Virus Infection by Blocking
Riva L; Goellner S; Biering SB; Huang CT; Rubanov AN; Haselmann U; Warnes CM; De Jesus PD; Martin-Sancho L; Terskikh AV; Harris E; Pinkerton AB; Bartenschlager R; Chanda SK
J Virol; 2021 Oct; 95(22):e0099621. PubMed ID: 34468177
[TBL] [Abstract][Full Text] [Related]
12. Antiviral activity of the FDA-approved drug candesartan cilexetil against Zika virus infection.
Loe MWC; Lee RCH; Chu JJH
Antiviral Res; 2019 Dec; 172():104637. PubMed ID: 31669333
[TBL] [Abstract][Full Text] [Related]
13. Discovery of a non-nucleoside RNA polymerase inhibitor for blocking Zika virus replication through in silico screening.
Pattnaik A; Palermo N; Sahoo BR; Yuan Z; Hu D; Annamalai AS; Vu HLX; Correas I; Prathipati PK; Destache CJ; Li Q; Osorio FA; Pattnaik AK; Xiang SH
Antiviral Res; 2018 Mar; 151():78-86. PubMed ID: 29274845
[TBL] [Abstract][Full Text] [Related]
14. Selective estrogen receptor modulator, tamoxifen, inhibits Zika virus infection.
Grady SF; Pinto AK; Hassert M; D'Angelo JA; Brien JD; Arnatt CK
J Med Virol; 2021 Nov; 93(11):6155-6162. PubMed ID: 34314058
[TBL] [Abstract][Full Text] [Related]
15. Antiviral activity of lycorine against Zika virus in vivo and in vitro.
Chen H; Lao Z; Xu J; Li Z; Long H; Li D; Lin L; Liu X; Yu L; Liu W; Li G; Wu J
Virology; 2020 Jul; 546():88-97. PubMed ID: 32452420
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of different cell systems for Zika virus (ZIKV) propagation and evaluation of anti-ZIKV compounds in vitro.
Vicenti I; Boccuto A; Giannini A; Dragoni F; Saladini F; Zazzi M
Virus Res; 2018 Jan; 244():64-70. PubMed ID: 29113824
[TBL] [Abstract][Full Text] [Related]
17. Antiviral activity of pinocembrin against Zika virus replication.
Lee JL; Loe MWC; Lee RCH; Chu JJH
Antiviral Res; 2019 Jul; 167():13-24. PubMed ID: 30959074
[TBL] [Abstract][Full Text] [Related]
18. Identification of Ascomycin against Zika virus infection through screening of natural product library.
Zhou L; Zhou J; Chen T; Chi X; Liu X; Pan S; Chen W; Wu T; Lin T; Zhang X; Li YP; Yang W
Antiviral Res; 2021 Dec; 196():105210. PubMed ID: 34801589
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationship of flavonoid bifunctional inhibitors against Zika virus infection.
Zou M; Liu H; Li J; Yao X; Chen Y; Ke C; Liu S
Biochem Pharmacol; 2020 Jul; 177():113962. PubMed ID: 32272109
[TBL] [Abstract][Full Text] [Related]
20. A cell-based assay to discover inhibitors of Zika virus RNA-dependent RNA polymerase.
Wang L; Zhou R; Liu Y; Guo S; Yi D; Zhao J; Li Q; Zhang Y; Liang C; Wang J; Shan G; Cen S
Virology; 2024 Jan; 589():109939. PubMed ID: 37979208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]